GO
Loading...

Idenix CEO on Hep C Drug Study

Tuesday, 14 Feb 2012 | 8:16 AM ET

Insight on the FDA clearing Idenix to resume study of its advanced experimental hepatitis C drug, with Ronald Renaud, Idenix president/CEO.